BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Labcritics - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Labcritics
X-ORIGINAL-URL:https://labcritics.com
X-WR-CALDESC:Events for Labcritics
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261026
DTEND;VALUE=DATE:20261028
DTSTAMP:20260923T120136Z
CREATED:20260923T120136Z
LAST-MODIFIED:20260923T120136Z
UID:15325-1792972800-1793145599@labcritics.com
SUMMARY:The Lantern Summit
DESCRIPTION:The Lantern Summit is an invitation-only biotech\, pharma\, clinical research and AIxBio conference in happening in Shanghai on 26–27 October 2026. It brings together biotech leaders from China\, Europe and the United States. Lantern Capital runs it. Lantern Capital is a fund that helps global deep-tech and biotech founders work in Asia\, led by co-founders Mia Deng and Gokhan Er. The summit’s tagline is “Accelerating Medicine Beyond Borders\,” and its goal is to connect the Chinese and Western biotech worlds to speed up drug discovery and patient access. \nWhat’s on the agenda: The program covers six themes: \n\nCross-border deal structures (NewCo\, co-development\, licensing)\nRunning clinical trials in China and whether global regulators accept the data\nRegulation and data rules\, such as China’s Order 818\nChinese big pharma as buyers and investors\nChinese science going global (ADCs\, cell therapy\, AI drug discovery)\nHow Western teams can set up in China\n\nDay 1 also has sessions on longevity\, “TechBio” (AI and automated labs) and brain-computer interfaces. \nSpeakers: They include executives from Hengrui\, XtalPi\, Novo Nordisk\, Pfizer\, SoftBank and Jones Day\, plus founders from both regions. \nThe dealmaking: The event is built around making deals between European/American and Chinese suppliers. Before the summit\, attendees fill in a survey saying what they need. Local partners then set up 1:1 meetings with CROs\, manufacturers\, hospitals\, investors and industrial parks. These happen in a dedicated “Deal Room.” On Day 2\, ten early-stage companies pitch on the main stage\, picked by a committee of VCs. Applications to pitch close 15 October. \nSchedule: There’s a welcome evening on 25 October. On 28 October there’s an optional $300 field trip to Suzhou BioBAY\, with a visit to a classical garden. \nPricing: \n\nFounders: $1\,500 early bird\, then $2\,200\nVCs\, pharma and service providers: $3\,500 early bird\, then $4\,500\n\nEarly-bird pricing ends 27 September\, four days from now.
URL:https://labcritics.com/upcoming-event/the-lantern-summit/
LOCATION:Shanghai\, Shanghai\, China
CATEGORIES:Biotechnology,Clinical Research
ATTACH;FMTTYPE=image/png:https://labcritics.com/wp-content/uploads/2026/09/Screenshot-2026-09-23-at-5.30.12-PM.png
ORGANIZER;CN="Lantern Capital":MAILTO:hello@lantern.capital
END:VEVENT
END:VCALENDAR